Inovio pharmaceuticals stock.

Important Documents. There are no documents available for this stock. Recent dividends ...Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.1 Mei 2020 ... Inovio Pharmaceuticals' stock has climbed higher and higher over the past month since it said it was working on a speedy COVID-19 vaccine.Mar 1, 2023 · Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021 Nasdaq 14,295.90 +0.39% +54.88 Russell 1,801.91 +0.042% +0.76 VIX 12.68 -0.079% -0.0100 Home INO • NASDAQ Inovio Pharmaceuticals Inc Follow Share $0.40 Nov 28, 11:47:07 AM GMT-5 · USD ·...

As of December 31, 2022, INOVIO had 253.1 million common shares outstanding and 271.0 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt.A high-level overview of Inovio Pharmaceuticals, Inc. (INO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The latest closing stock price for Inovio Pharmaceuticals as of November 17, 2023 is 0.43. The all-time high Inovio Pharmaceuticals stock closing price was 191.04 on March 03, 2000. The Inovio Pharmaceuticals 52-week high stock price is 2.17, which is 404.7% above the current share price. The Inovio Pharmaceuticals 52-week low stock price is 0. ...

Inovio Pharmaceuticals, Inc. Common Stock (INO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

3 Jan 2023 ... This could mean hype has come out of the stock because the bottom line is concerning investors. Generally speaking investors would consider ...Aug 9, 2023 · Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received Orphan Drug Designation from European Commission in second quarter Scaling resources and headcount to align with strategic focus on INO-3107 and late-stage clinical candidates closest to market and with greatest opportunity to deliver on the promise of DNA medicines for ... Lead Case No. 2:20-cv-01962-GJP. NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER. DERIVATIVE ACTIONS. TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF INOVIO PHARMACEUTICALS, INC ...ROBERT J. JUBA JR. “INOVIO’s team has extensive experience manufacturing DNA medicines and a proven track record of producing them at unprecedented speeds.”. “INOVIO’s CELLECTRA® intramuscular and intracellular smart devices have allowed us to deliver our optimized DNA plasmids directly into cells in the body to produce immune responses. J. Joseph Kim, co-founder and former CEO of Inovio Pharmaceuticals. ... Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38.

Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.Web

Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38. It opened Friday at $2.51 per share.

Biotechnology firm Inovio Pharmaceuticals (INO) was one of the first companies to enter the race to release a Covid-19 vaccine, but delays have set back the process and it remains in the development stage. The company’s share price fell in late 2020, but it has gained 19 per cent so far this year, with the firm moving ahead with …Inovio Pharmaceuticals. Market Cap. $111M. Today's Change. (2.77%) $0.01. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ...The stock price of Inovio Pharmaceuticals (NYSE: INO), a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, reached its 52-week high levels of ...Nov 1, 2023 · The stock option has an exercise price of $0.36, the closing price of INOVIO's common stock on the Grant Date. The stock option will vest and become exercisable with respect to one-fourth of the shares underlying the stock option vested on the Grant Date, and an additional one-fourth of the shares underlying the stock option on the first ... After market hours on Tuesday, Inovio revealed that it booked revenue of $839,000 in its fourth quarter of 2021, well down from the $5.6 million in the same quarter the previous year. The net loss ...

Biotechnology firm Inovio Pharmaceuticals (INO) was one of the first companies to enter the race to release a Covid-19 vaccine, but delays have set back the process and it remains in the development stage. The company’s share price fell in late 2020, but it has gained 19 per cent so far this year, with the firm moving ahead with …Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading marginally lower by 0.93% to $2.12 after the company reported Menu icon A vertical stack of three evenly spaced horizontal lines.WebInovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors from a year ago are still down 69%. (Simply Wall St.) Nov-18-22 11:42AM. Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs. Green flag: A rich pipeline. Small-cap biotechs need promising pipeline programs to attract attention. In this department, Inovio Pharmaceuticals doesn't disappoint. The company currently boasts ...Dec 21, 2021 · The Food and Drug Administration reversed a decision that barred Inovio Pharmaceuticals from testing its ... Inovio stock hit a high mark of 33.79 in June 2020 after the biotech company received a ... Earnings for Inovio Pharmaceuticals are expected to grow in the coming year, from ($0.48) to ($0.30) per share. Inovio Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates.Web21 Des 2021 ... Inovio Pharmaceuticals (INO) ... The shares have a poor EPS Rating of 18. This reflects INO stock's continuing losses per share. On Dec. 21, ...

Inovio Pharmaceuticals (INO-5.75%) stock rose slightly on an otherwise gloomy day for the wider market. Investors were cheered by the appointment of a new chief medical officer at their company.

Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ... Inovio Pharmaceuticals Inc (NASDAQ:INO) 0.4291. Delayed Data. As of Nov 17 ...Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript. Good afternoon, and thank you for joining the Inovio 2023 third quarter conference call. Joining me on today's call are Dr. Jackie ...Inovio Pharmaceuticals Inc. share price in real-time (A115GK / US45773H2013), charts and analyses, news, key data, turnovers, company data. Name / WKN / ISIN / Symbol Help Contact DeutschWebInovio Pharmaceuticals, Inc. Common Stock (INO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Nasdaq 14,295.90 +0.39% +54.88 Russell 1,801.91 +0.042% +0.76 VIX 12.68 -0.079% -0.0100 Home INO • NASDAQ Inovio Pharmaceuticals Inc Follow Share $0.40 Nov 28, 11:47:07 AM GMT-5 · USD ·...The proposed Settlement will create a cash settlement fund of $30,000,000 in cash and 7,000,000 shares of Inovio common stock (the "Settlement Stock") to be ...INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that data from a Phase 1b trial evaluating INO-4201 as an Ebola booster vaccine candidate for rVSV-ZEBOV (Ervebo) ( …Find the latest Inovio Pharmaceuticals, Inc. (INO.MX) stock quote, history, news and other vital information to help you with your stock trading and investing.WebThe Food and Drug Administration reversed a decision that barred Inovio Pharmaceuticals from testing its Covid vaccine in the U.S., and INO stock popped.. X. Inovio is working on a vaccine-device ...

A high-level overview of Inovio Pharmaceuticals, Inc. (INO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Inovio Pharmaceuticals ' ( INO 4.66%) stock rose by more than 18.5% as of 2:30 p.m. ET on Wednesday after the company's Q2 earnings results broke the news of its plans to restructure its ...Web

Inovio Pharmaceuticals (INO 4.20%) ... This leads to the biggest concern of all about Inovio. The biotech stock has skyrocketed in 2020 based on expectations of success for its COVID-19 vaccine ...Inovio Pharmaceuticals is a small-ish biotech company with a market cap of around $519 million. The company ended 2022's second quarter with $348 million in cash and short-term investments, which ...Inovio Pharmaceuticals (INO-5.34%) has given different groups of investors some wildly varying stock performances this year. If you bought its shares at the beginning of 2020, your investment is ...INO stock forecast for 2023 – 2027. Last updated: November 10, 2023. Inovio Pharmaceuticals, Inc. 0.3497 D 3.42% (0.0124)52-week High/Low: $2.07 / $0.32. 50/200 Day Moving Average: $0.407 / $0.664. This figure corresponds to the Average Price over the previous 50/200 days. For Inovio Pharmaceuticals stocks, the 50-day moving average is the support level today. For Inovio Pharmaceuticals stocks, the 200-day moving average is the resistance level today.WebNov 17, 2021 · It's been a rough 12 months for Inovio Pharmaceuticals (INO-3.67%).In the past year, shares of the company have declined by 35% while the S&P 500 has risen 30%. The main reason for this abysmal ... Mar 1, 2023 · As of December 31, 2022, INOVIO had 253.1 million common shares outstanding and 271.0 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and ... Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2021 and 2020Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript November 9, 2023 Inovio Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS ...Inovio Pharmaceuticals, Inc. Common Stock (INO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Morningstar Financial Research conducts Analysis on Markets, Mutual Fund, Stocks and ETFs through Investment Data and News.Get a real-time Inovio Pharmaceuticals, Inc. (INO) stock price quote with breaking news, financials, statistics, charts and more.

Inovio Pharmaceuticals (INO-5.34%) has given different groups of investors some wildly varying stock performances this year. If you bought its shares at the beginning of 2020, your investment is ...In a nutshell, Inovio Pharmaceuticals Inc (INO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.if you purchased or acquired inovio pharmaceuticals, inc.(“inovio”) common stock from february 14, 2020 through august 10, 2020, inclusive (the “class”), you could receive a payment from a ...Aug 9, 2023 · Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received Orphan Drug Designation from European Commission in second quarter Scaling resources and headcount to align with strategic focus on INO-3107 and late-stage clinical candidates closest to market and with greatest opportunity to deliver on the promise of DNA medicines for ... Instagram:https://instagram. healthstream incstock lunrmarca real madridpsychedelic stocks etf From 1998 through today, Inovio Pharmaceuticals' stock history has been largely a depressing one. A quick analysis of Inovio Pharmaceuticals ' ( INO 2.77%) stock performance history shows plenty ... ngg futures2023 stock market forecast Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. best financial advisors houston BLUE BELL, Pa., May 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M ...WebThese factors combined to bring our net loss for the second quarter of 2023 to $35.5 million or $0.13 per share basic and dilutive, compared to a net loss of $108.5 million or $0.46 per share ...